Published in Am J Physiol Cell Physiol on January 28, 2004
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
CaMKII in the cardiovascular system: sensing redox states. Physiol Rev (2011) 1.67
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol (2010) 1.46
Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem (2005) 1.13
Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front Biosci (Landmark Ed) (2009) 1.07
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol (2005) 1.05
The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol (2008) 1.03
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
Atherosclerosis: A Link Between Lipid Intake and Protein Tyrosine Nitration. Lipid Insights (2008) 0.79
Regulation of the cardiac sodium/bicarbonate cotransporter by angiotensin II: potential Contribution to structural, ionic and electrophysiological myocardial remodelling. Curr Cardiol Rev (2013) 0.76
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem (2002) 3.17
A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients. Urology (2009) 2.06
Inflammation in atherosclerosis and implications for therapy. Circulation (2004) 1.71
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol (2010) 1.46
Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol (2008) 1.15
CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascul Pharmacol (2004) 1.13
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation (2004) 1.03
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res (2013) 0.99
Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J Biol Chem (2009) 0.98
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol (2009) 0.97
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem (2002) 0.95
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36. Circulation (2004) 0.95
Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. Methods Enzymol (2008) 0.95
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res (2006) 0.95
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2007) 0.94
Detection of low abundance RNA molecules in individual cells by flow cytometry. PLoS One (2013) 0.93
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. J Lipid Res (2003) 0.92
Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol (2015) 0.91
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem (2003) 0.90
The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production. Neurobiol Dis (2011) 0.89
Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. J Biol Chem (2007) 0.87
Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression. J Biol Chem (2012) 0.87
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
Activation of liver X receptor induces macrophage interleukin-5 expression. J Biol Chem (2012) 0.84
Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat (2006) 0.84
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications. Med Care (2016) 0.84
Tyrosine nitration in prostaglandin H(2) synthase. J Lipid Res (2002) 0.83
A 57-year-old man with a history of prostatectomy and pelvic irradiation presents with recurrent urinary tract infections, hematuria, and pelvic pain. Urology (2013) 0.81
Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase. Am J Physiol Heart Circ Physiol (2013) 0.81
Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease. Curr Hypertens Rev (2009) 0.80
Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Value Health (2013) 0.80
Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology (2008) 0.80
Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress. J Am Chem Soc (2010) 0.80
Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. Hypertension (2007) 0.80
Endoscopic endonasal resection of skull base chondrosarcomas: technique and early results. J Neurosurg (2015) 0.79
Functional outcomes after treatment for prostate cancer. N Engl J Med (2013) 0.79
Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. Biochem J (2013) 0.79
Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. Am J Physiol Heart Circ Physiol (2011) 0.78
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int (2014) 0.78
Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages. Atherosclerosis (2012) 0.77
Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. Can J Urol (2010) 0.77
Complex "cross talk" involving nitric oxide metabolites: who's listening? Curr Atheroscler Rep (2006) 0.76
Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells. Eur J Pharmacol (2009) 0.76
Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Curr Opin Oncol (2012) 0.75
Editorial comment. J Urol (2012) 0.75
Editorial comment. Urology (2012) 0.75
Re: Health Care Hotspotting-A Randomized, Controlled Trial. J Urol (2020) 0.75
Socioeconomic Factors, Urological Epidemiology and Practice Patterns. J Urol (2022) 0.75
Reprint of "oxidative alterations of cyclooxygenase during atherogenesis" [Prostag. Oth. Lipid. M. 80 (2006) 1-14]. Prostaglandins Other Lipid Mediat (2007) 0.75
Short term complications from transurethral resection of bladder tumor. Can J Urol (2016) 0.75
Re: Association between Automotive Assembly Plant Closures and Opioid Overdose Mortality in the United States: A Difference-in-Differences Analysis. J Urol (2020) 0.75
The impact of residency match information disseminated by a third-party website. J Surg Educ (2009) 0.75
The influence of provider characteristics and market forces on response to financial incentives. Am J Manag Care (2017) 0.75
Bladder cancer: improvements in clinical staging of muscle-invasive bladder cancer. Nat Rev Urol (2011) 0.75
Socioeconomic Factors, Urological Epidemiology and Practice Patterns. J Urol (2021) 0.75
Developments and controversies in the management of noninvasive bladder cancer. Curr Opin Oncol (2014) 0.75